Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Wednesday newspaper round-up: Shell, Wise, Sensyne Health
(Sharecast News) - It has been another record year for renewable energy, despite the Covid-19 pandemic and rising costs for raw materials around the world, according to the International Energy Agency (IEA). About 290GW of new renewable energy generation capacity, mostly in the form of wind turbines and solar panels, has been installed around the world this year, beating the previous record last year. On current trends, renewable energy generating capacity will exceed that of fossil fuels and nuclear energy combined by 2026. - Guardian An 11th hour bid has been launched to try to halt plans by Royal Dutch Shell to explore for oil in vital whale breeding grounds along the Wild Coast of eastern South Africa. Campaigners filed an urgent legal challenge against the seismic survey, which was scheduled to begin on Wednesday, in a last-ditch bid to prevent it harming whales, dolphins and seals in the relatively untouched marine environment. - Guardian
Directors at the money transfer company Wise have told its billionaire chief executive to hire professional advisers after he was fined for defaulting on his taxes Wise said its board had launched a review after Kristo Kaarmann, its co-founder, was penalised for late payment of his personal tax bill in 2017/18. - Telegraph
The healthcare technology company led by Lord Drayson, the former business and science minister, has been fined and censured by the London stock exchange for "serious failures" relating to the secret payment of £1 million of executive bonuses, including to the peer. An investigation by the exchange has found that Sensyne Health misled Peel Hunt, the company's nominated adviser, over cash bonuses of £850,000 to Drayson, the founder, chief executive and largest shareholder, and £200,000 to Lorimer Headley, its chief financial officer at the time. - The Times
Financial firms face a "shock" rise of more than 90 per cent in the minimum cost of being regulated, under new proposals from the City watchdog. The Financial Conduct Authority's regulatory fee and levies proposals for next year set out an increase from £1,151 to £2,200 in what firms must pay. The plans relate to its "Block A" category, which includes small firms paying the minimum cost of being regulated. The amount a firm pays depends on the type and extent of regulated activity it carries out and how much it costs to oversee those activities. - The Times
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.